Viewing Study NCT02056756


Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2026-02-20 @ 6:01 PM
Study NCT ID: NCT02056756
Status: COMPLETED
Last Update Posted: 2024-02-20
First Post: 2014-02-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Carfilzomib In Combination With Bendamustine And Dexamethasone In Refractory Or Relapsed Multiple Myeloma
Sponsor: Stichting European Myeloma Network
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None REFRACTORY OR RELAPSED View
None CBD View